The Medical and Surgical Practice of NaProTECHNOLOGY, 607-634, 2004
Chapter 46: Medical Treatment of Ovarian Dysfunction
Author affiliations
- Pope Paul VI Institute for the Study of Human Reproduction, Omaha, Nebraska. ROR
Abstract
Ovarian dysfunction — encompassing luteal insufficiency, abnormal folliculogenesis, and anovulation — is treated in NaProTECHNOLOGY with cycle-timed interventions including HCG trigger, progesterone supplementation, clomiphene, and thyroid optimization, guided by prospective CrMS charting rather than protocol-driven stimulation. This approach normalizes endogenous hormonal patterns rather than overriding them, preserving uterine receptivity and reducing multiple gestation risk.
Topics
Cite this article
Hilgers, T. W. (2004). Chapter 46: Medical Treatment of Ovarian Dysfunction. *The Medical and Surgical Practice of NaProTECHNOLOGY*, 607-634.
Hilgers TW. Chapter 46: Medical Treatment of Ovarian Dysfunction. The Medical and Surgical Practice of NaProTECHNOLOGY. 2004:607-634.
Hilgers, T. W. "Chapter 46: Medical Treatment of Ovarian Dysfunction." *The Medical and Surgical Practice of NaProTECHNOLOGY*, 2004, pp. 607-634.